Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-04 Sale |
2025-03-05 4:44 pm |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
4,109 | $1.7108 | $7,030 | 112,720 (Direct) |
View |
2024-08-14 Purchase |
2024-08-15 5:09 pm |
Beyond Air Inc. | XAIR | Lucera Erick Director |
39,266 | $0.3964 | $15,565 | 43,608 (Direct) |
View |
2024-05-20 Sale |
2024-05-22 4:30 pm |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
22,337 | $5.6142 | $125,404 | 116,829 (Direct) |
View |
2023-03-16 Purchase |
2023-03-20 4:10 pm |
Beyond Air Inc. | XAIR | Lucera Erick Director |
2,000 | $6.817 | $13,634 | 4,342 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-31 Option Award |
2025-04-01 4:33 pm |
N/A 2035-03-30 |
Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer |
280,600 | $0 | 280,600 (Direct) |
View |
2025-03-26 Option Award |
2025-03-28 5:12 pm |
N/A 2035-03-26 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
75,000 | $0 | 75,000 (Direct) |
View |
2025-03-08 Option Award |
2025-03-27 4:41 pm |
N/A 2035-03-07 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
345,100 | $0 | 345,100 (Direct) |
View |
2024-11-22 Option Award |
2024-11-26 9:54 pm |
N/A N/A |
Beyond Air Inc. | XAIR | Lucera Erick Director |
210,000 | $0 | 210,000 (Direct) |
View |
2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Lucera Erick Director |
20,000 | $0 | 20,000 (Direct) |
View |
2024-03-20 Option Award |
2024-03-21 9:01 pm |
N/A 2034-03-20 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
45,000 | $0 | 45,000 (Direct) |
View |
2024-03-02 Option Award |
2024-03-05 8:06 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
167,266 | $0 | 245,166 (Direct) |
View |
2023-09-18 Option Award |
2023-09-20 2:54 pm |
N/A 2033-09-13 |
Bone Biologics Corp | BBLG | Lucera Erick Director |
85,763 | $0 | 88,059 (Direct) |
View |
2023-05-17 Option Award |
2023-05-18 5:20 pm |
N/A 2033-05-16 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
233,700 | $0 | 233,700 (Direct) |
View |
2023-04-03 Option Award |
2023-04-05 5:01 pm |
N/A 2033-04-03 |
SAB Biotherapeutics Inc. | SABS | Lucera Erick Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 4:15 pm |
N/A 2033-03-28 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-08-23 Option Award |
2023-03-08 06:20 am |
N/A 2027-08-23 |
Bone Biologics Corp | BBLG | Lucera Erick Director |
36,845 | $0 | 68,516 (Direct) |
View |
2022-03-03 Option Award |
2022-03-07 08:33 am |
N/A 2032-03-02 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
30,000 | $0 | 30,000 (Direct) |
View |
2021-10-26 Option Award |
2022-02-28 06:02 am |
2021-12-31 2031-10-26 |
Bone Biologics Corp | BBLG | Lucera Erick Director |
11,671 | $0 | 54,620 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 5:00 pm |
N/A 2032-02-15 |
AVEO PHARMACEUTICALS INC. | AVEO | Lucera Erick Chief Financial Officer |
218,800 | $0 | 218,800 (Direct) |
View |
Ownership |
2021-10-21 5:20 pm |
2021-10-15 2031-10-15 |
Bone Biologics Corp | BBLG | Lucera Erick Director |
0 | $0 | 50,000 (Direct) |
View |
2021-02-05 Option Award |
2021-04-16 4:05 pm |
N/A 2031-02-05 |
AVEO PHARMACEUTICALS INC. | AVEO | Lucera Erick Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2021-03-04 Option Award |
2021-03-08 7:57 pm |
N/A 2031-03-03 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
25,000 | $0 | 25,000 (Direct) |
View |
2021-02-16 Exercise |
2021-03-03 5:50 pm |
2018-02-16 2021-02-16 |
Beyond Air Inc. | XAIR | Lucera Erick Director |
1,171 | $0 | 2,342 (Direct) |
View |
2021-02-16 Exercise |
2021-03-03 5:50 pm |
N/A N/A |
Beyond Air Inc. | XAIR | Lucera Erick Director |
1,171 | $4.25 | 2,342 (Direct) |
View |